Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis

Description

Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis

Conditions

Open-Angle Glaucoma

Talk to us

Study Overview

On this page

Study Details

Study overview

Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis

Real-World Efficacy of Hydrus Microstent With OMNI Surgical System in Combination With Phacoemulsification: a Retrospective Analysis

Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis

Condition
Open-Angle Glaucoma
Intervention / Treatment

-

Contacts and Locations

Mesa

Barnet Dulaney Perkins Eye Center, Mesa, Arizona, United States, 85206

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Subjects with h/o CEIOL/OMNI/Hydrus (chosen based on subjects on more than 1 medication pre-operatively) with at least 3 years of follow up data
  • * have Glaucoma
  • * Patients with angle closure glaucoma or secondary forms of glaucoma due to neovascularization of the angle, uveitic glaucoma, congenital glaucoma, or glaucoma due to congenital anomalies.
  • * Patients with refractory CME or CME persisting 3 months or more post-operatively
  • * Patients with incomplete IOP, medication logs or VF data within post-operative period
  • * Prior incisional surgery or MIGS

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Barnet Dulaney Perkins Eye Centers,

Christine Funke, Medical Doctor, PRINCIPAL_INVESTIGATOR, Barnet Dulaney Perkins Eye Centers

Study Record Dates

2025-12-31